Hospitalized Patients’ Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist’s Classroom-Based Education
Objective: Assess if a classroom-based pharmacy education service for hospitalized headache patients newly prescribed a monoamine oxidase inhibitor (MAOI) results in, 1) higher self-perceived medication knowledge, or 2) lower perceived risk of using MAOIs.Subjects: Individuals admitted to an inpatie...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Minnesota Libraries Publishing
2010-01-01
|
Series: | INNOVATIONS in Pharmacy |
Online Access: | http://www.pharmacy.umn.edu/innovations/prod/groups/cop/@pub/@cop/@innov/documents/content/cop_content_212864.pdf |
_version_ | 1818579788217974784 |
---|---|
author | Richard G. Wenzel, Pharm.D Jon C. Schommer, Ph.D. |
author_facet | Richard G. Wenzel, Pharm.D Jon C. Schommer, Ph.D. |
author_sort | Richard G. Wenzel, Pharm.D |
collection | DOAJ |
description | Objective: Assess if a classroom-based pharmacy education service for hospitalized headache patients newly prescribed a monoamine oxidase inhibitor (MAOI) results in, 1) higher self-perceived medication knowledge, or 2) lower perceived risk of using MAOIs.Subjects: Individuals admitted to an inpatient headache unit over a five month periodMethods: Patient survey administered before and after the education service to any patient newly prescribed an MAOI. Results: Seventy-eight individuals completed the study. Paired-samples t-tests showed that for each of the four items related to selfperceived medication knowledge, the scores reflected higher knowledge after the MAOI class compared to before the class (p < 0.05). For three out of the four items related to perceived risk of using MAOIs, the scores reflected a lower level of perceived risk after the MAOI class compared to before the class (p < 0.05). One item did not significantly change: “The MAOI prescribed for me is just as good as other products available for treating headache.”Conclusion: Our results demonstrate a pharmacist-conducted, classroom-based teaching method for newly prescribed MAOI patients can result in higher self-perceived medication knowledge and lower perceived risks. |
first_indexed | 2024-12-16T07:07:16Z |
format | Article |
id | doaj.art-f142a668799048fca8da1ea1ff1df7af |
institution | Directory Open Access Journal |
issn | 2155-0417 |
language | English |
last_indexed | 2024-12-16T07:07:16Z |
publishDate | 2010-01-01 |
publisher | University of Minnesota Libraries Publishing |
record_format | Article |
series | INNOVATIONS in Pharmacy |
spelling | doaj.art-f142a668799048fca8da1ea1ff1df7af2022-12-21T22:40:00ZengUniversity of Minnesota Libraries PublishingINNOVATIONS in Pharmacy2155-04172010-01-01115Hospitalized Patients’ Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist’s Classroom-Based EducationRichard G. Wenzel, Pharm.DJon C. Schommer, Ph.D.Objective: Assess if a classroom-based pharmacy education service for hospitalized headache patients newly prescribed a monoamine oxidase inhibitor (MAOI) results in, 1) higher self-perceived medication knowledge, or 2) lower perceived risk of using MAOIs.Subjects: Individuals admitted to an inpatient headache unit over a five month periodMethods: Patient survey administered before and after the education service to any patient newly prescribed an MAOI. Results: Seventy-eight individuals completed the study. Paired-samples t-tests showed that for each of the four items related to selfperceived medication knowledge, the scores reflected higher knowledge after the MAOI class compared to before the class (p < 0.05). For three out of the four items related to perceived risk of using MAOIs, the scores reflected a lower level of perceived risk after the MAOI class compared to before the class (p < 0.05). One item did not significantly change: “The MAOI prescribed for me is just as good as other products available for treating headache.”Conclusion: Our results demonstrate a pharmacist-conducted, classroom-based teaching method for newly prescribed MAOI patients can result in higher self-perceived medication knowledge and lower perceived risks.http://www.pharmacy.umn.edu/innovations/prod/groups/cop/@pub/@cop/@innov/documents/content/cop_content_212864.pdf |
spellingShingle | Richard G. Wenzel, Pharm.D Jon C. Schommer, Ph.D. Hospitalized Patients’ Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist’s Classroom-Based Education INNOVATIONS in Pharmacy |
title | Hospitalized Patients’ Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist’s Classroom-Based Education |
title_full | Hospitalized Patients’ Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist’s Classroom-Based Education |
title_fullStr | Hospitalized Patients’ Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist’s Classroom-Based Education |
title_full_unstemmed | Hospitalized Patients’ Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist’s Classroom-Based Education |
title_short | Hospitalized Patients’ Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist’s Classroom-Based Education |
title_sort | hospitalized patients perceived knowledge and risk of monoamine oxidase inhibitor medications before and after a pharmacist s classroom based education |
url | http://www.pharmacy.umn.edu/innovations/prod/groups/cop/@pub/@cop/@innov/documents/content/cop_content_212864.pdf |
work_keys_str_mv | AT richardgwenzelpharmd hospitalizedpatientsperceivedknowledgeandriskofmonoamineoxidaseinhibitormedicationsbeforeandafterapharmacistsclassroombasededucation AT joncschommerphd hospitalizedpatientsperceivedknowledgeandriskofmonoamineoxidaseinhibitormedicationsbeforeandafterapharmacistsclassroombasededucation |